Vontobel Holding
IOVA icon

Vontobel Holding’s Iovance Biotherapeutics IOVA Stock Holding History

Vontobel Holding’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,067
Closed -$26.2K – 1478
2025
Q3 		$26.2K Buy
+12,067
New +$28.5K ﹤0.01% 1340
2025
Q1 		– Sell
-19,375
Closed -$143K – 1124
2024
Q4 		$143K Buy
19,375
+435
+2% +$4.03K ﹤0.01% 1033
2024
Q3 		$178K Buy
18,940
+4,647
+33% +$44K ﹤0.01% 1016
2024
Q2 		$115K Buy
+14,293
New +$153K ﹤0.01% 1020
2023
Q4 		– Sell
-139,014
Closed -$633K – 1135
2023
Q3 		$633K Sell
139,014
-3,284
-2% -$21.4K 0.01% 699
2023
Q2 		$1M Buy
+142,298
New +$1.02M 0.01% 596

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vontobel Holding's IOVA Position: Q4 2025 in Review

Vontobel Holding sold out of Iovance Biotherapeutics (IOVA) in Q4 2025, closing a stake of 12,067 shares — an estimated $26.2K sold.

Vontobel Holding first reported a position in IOVA in Q2 2023 and held it in 6 quarters. The position peaked at $1M in Q2 2023. 263 funds tracked by Wall St. Rank hold IOVA as of Q4 2025.

  • Vontobel Holding reported no remaining Iovance Biotherapeutics position as of Q4 2025 after selling out during the quarter.
  • Vontobel Holding sold 12,067 Iovance Biotherapeutics shares in Q4 2025, an estimated $26.2K.
  • Vontobel Holding first reported a position in Iovance Biotherapeutics in Q2 2023 and held it in 6 quarters.
  • Vontobel Holding's Iovance Biotherapeutics position peaked at $1M in Q2 2023.
  • 263 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2025.

Based on Vontobel Holding's 13F filing for Q4 2025, filed 13 Feb 2026.